1. Home
  2. MNKD vs GFR Comparison

MNKD vs GFR Comparison

Compare MNKD & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.72

Market Cap

793.6M

Sector

Health Care

ML Signal

HOLD

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

HOLD

Current Price

$6.26

Market Cap

836.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
GFR
Founded
1991
2018
Country
United States
Canada
Employees
N/A
197
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.6M
836.6M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MNKD
GFR
Price
$2.72
$6.26
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$8.56
N/A
AVG Volume (30 Days)
4.5M
246.4K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$348,966,000.00
N/A
Revenue This Year
$35.81
N/A
Revenue Next Year
$11.89
N/A
P/E Ratio
$138.50
$4.33
Revenue Growth
22.23
N/A
52 Week Low
$2.23
$3.81
52 Week High
$6.51
$7.02

Technical Indicators

Market Signals
Indicator
MNKD
GFR
Relative Strength Index (RSI) 44.75 52.03
Support Level $2.52 $5.62
Resistance Level $4.09 $6.92
Average True Range (ATR) 0.11 0.27
MACD 0.11 -0.03
Stochastic Oscillator 88.99 53.26

Price Performance

Historical Comparison
MNKD
GFR

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

Share on Social Networks: